|
1
|
Brandes AA, Tosoni A, Franceschi E, Sotti
G, Frezza G, Amistà P, Morandi L, Spagnolli F and Ermani M:
Recurrence pattern after temozolomide concomitant with and adjuvant
to radiotherapy in newly diagnosed patients with glioblastoma:
Correlation with MGMT promoter methylation status. J Clin Oncol.
27:1275–1279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ru Q, Tian X, Wu YX, Wu RH, Pi MS and Li
CY: Voltage-gated and ATP-sensitive K+ channels are associated with
cell proliferation and tumorigenesis of human glioma. Oncol Rep.
31:842–848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathupala SP, Mittal S, Guthikonda M and
Sloan AE: MicroRNA and brain tumors: A cause and a cure? DNA Cell
Biol. 26:301–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gabriely G, Yi M, Narayan RS, Niers JM,
Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM, et
al: Human glioma growth is controlled by microRNA-10b. Cancer Res.
71:3563–3572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji Y, Wei Y, Wang J, Gong K, Zhang Y and
Zuo H: Correlation of microRNA-10b upregulation and poor prognosis
in human gliomas. Tumour Biol. 36:6249–6254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guessous F, Alvarado-Velez M,
Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J,
Schiff D, Purow B and Abounader R: Oncogenic effects of miR-10b in
glioblastoma stem cells. J Neurooncol. 112:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin J, Teo S, Lam DH, Jeyaseelan K and
Wang S: MicroRNA-10b pleiotropically regulates invasion,
angiogenicity and apoptosis of tumor cells resembling mesenchymal
subtype of glioblastoma multiforme. Cell Death Dis. 3:e3982012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ru Q, Li WL, Xiong Q, Chen L, Tian X and
Li CY: Voltage-gated potassium channel blocker 4-aminopyridine
induces glioma cell apoptosis by reducing expression of
microRNA-10b-5p. Mol Biol Cell. 29:1125–1136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weiss FU, Marques IJ, Woltering JM,
Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM and
Bagowski CP: Retinoic acid receptor antagonists inhibit miR-10a
expression and block metastatic behavior of pancreatic cancer.
Gastroenterology. 137:2136–2145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen H, Fan Y, Xu W, Chen J, Xu C, Wei X,
Fang D and Feng Y: miR-10b inhibits apoptosis and promotes
proliferation and invasion of endometrial cancer cells via
targeting HOXB3. Cancer Biother Radiopharm. 31:225–231. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang D, Yan R and Zhang X, Zhu Z, Wang C,
Liang C and Zhang X: Deregulation of MicroRNA-375 inhibits cancer
proliferation migration and chemosensitivity in pancreatic cancer
through the association of HOXB3. Am J Transl Res. 8:1551–1559.
2016.PubMed/NCBI
|
|
15
|
Hussain R, Umer HM, Björkqvist M and
Roomans GM: ENaC, iNOS, mucins, and wound healing in cystic
fibrosis airway epithelial and submucosal cells. Cell Biol Int Rep.
21:25–38. 2014.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mayes DA, Hu Y, Teng Y, Siegel E, Wu X,
Panda K, Tan F, Yung WK and Zhou YH: PAX6 suppresses the
invasiveness of glioblastoma cells and the expression of the matrix
metalloproteinase-2 gene. Cancer Res. 66:9809–9817. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang H, Okamoto Y, Yokoo H, Heppner FL,
Vital A, Fevre-Montange M, Jouvet A, Yonekawa Y, Lazaridis EN,
Kleihues P and Ohgaki H: Gene expression profiling and subgroup
identification of oligodendrogliomas. Oncogene. 23:6012–6022. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Angelopoulou E, Piperi C, Adamopoulos C
and Papavassiliou AG: Pivotal role of high-mobility group box 1
(HMGB1) signaling pathways in glioma development and progression. J
Mol Med (Berl). 94:867–874. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gabriely G, Teplyuk NM and Krichevsky AM:
Context effect: microRNA-10b in cancer cell proliferation, spread
and death. Autophagy. 7:1384–1386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang
J, Wang X, You Y, Yang Z and Liu N: MicroRNA-10b induces glioma
cell invasion by modulating MMP-14 and uPAR expression via HOXD10.
Brain Res. 1389:9–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong CG, Wu WK, Feng SY, Wang XJ, Shao JF
and Qiao J: Co-inhibition of microRNA-10b and microRNA-21 exerts
synergistic inhibition on the proliferation and invasion of human
glioma cells. Int J Oncol. 41:1005–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu H, Fu L, Xie C, Zuo WS, Liu YS, Zheng
MZ and Yu JM: miR-375 inhibits cancer stem cell phenotype and
tamoxifen resistance by degrading HOXB3 in human ER-positive breast
cancer. Oncol Rep. 37:1093–1099. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J, Zhu S, Jiang N, Shang Z, Quan C
and Niu Y: HoxB3 promotes prostate cancer cell progression by
transactivating CDCA3. Cancer Lett. 330:217–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Liu C and Hou R: Knockdown of
HMGB1 improves apoptosis and suppresses proliferation and invasion
of glioma cells. Chin J Cancer Res. 26:658–668. 2014.PubMed/NCBI
|
|
27
|
Gu J, Xu R, Li Y, Zhang J and Wang S:
MicroRNA-218 modulates activities of glioma cells by targeting
HMGB1. Am J Transl Res. 8:3780–3790. 2016.PubMed/NCBI
|
|
28
|
Yang Y, Huang JQ, Zhang X and Shen LF:
MiR-129-2 functions as a tumor suppressor in glioma cells by
targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell
Biochem. 404:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fiuza C, Bustin M, Talwar S, Tropea M,
Gerstenberger E, Shelhamer JH and Suffredini AF:
Inflammation-promoting activity of HMGB1 on human microvascular
endothelial cells. Blood. 101:2652–2660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Treutiger CJ, Mullins GE, Johansson AS,
Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H,
Tracey KJ, Andersson J and Palmblad JE: High mobility group 1 B-box
mediates activation of human endothelium. J Intern Med.
254:375–385. 2003. View Article : Google Scholar : PubMed/NCBI
|
